Vascular Disease: Clinical Trials

6 trials for Vascular Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Vascular Disease: new trials by email Literature Review of Vascular Disease trials Research Report on Vascular Disease

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
Dexamethasone infusion, Drug coated balloon, Plain balloon angioplasty - Peripheral Artery Disease, Vascular Disease
Phase 4CompletedUniversity of California, San Francisco332016-02-102025-07-17
Clinical Trial of a Silver Eluting Dressing System
Surgical dressing - Vascular Disease, Surgery
Phase 4CompletedBrigham and Women's Hospital5002010-10-012016-01-12
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)
XIENCE V EECSS, CYPHER SELECT PLUS SECSS - Coronary Occlusion, Thrombosis (Stent Thrombosis)
Phase 4CompletedAbbott Medical Devices5462010-08-012016-08-24
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
placebo + aspirin, clopidogrel + aspirin OR prasugrel + aspirin, XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS) - Chronic Total Occlusion of Coronary Artery, Vascular Disease
Phase 4CompletedAbbott Medical Devices8702009-08-012023-11-14
XIENCE V: SPIRIT WOMEN Sub-study
XIENCE V®/ XIENCE PRIME™, CYPHER SELECT - Coronary Artery Stenosis, Coronary Arteriosclerosis
Phase 4CompletedAbbott Medical Devices4552008-09-012012-08-07
XIENCE V: SPIRIT WOMEN
XIENCE V®/ XIENCE PRIME™ - Coronary Artery Stenosis, Coronary Arteriosclerosis
Phase 4CompletedAbbott Medical Devices16002007-07-012015-05-13

Narrower conditions

Vascular Diseases (6)  ·  Coronary Artery Disease (4)  ·  Coronary Restenosis (4)  ·  Coronary Stenosis (4)  ·  Myocardial Ischemia (4)  ·  Coronary Disease (2)  ·  Atherosclerosis (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Coronary Occlusion (1)  ·  Intermittent Claudication (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Thrombosis (1)  ·  Wound Infection (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Arterial Occlusive Diseases (5)  ·  Arteriosclerosis (5)  ·  Heart Diseases (4)  ·  Coronary Disease (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Embolism and Thrombosis (1)  ·  Infections (1)  ·  Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Aspirin (1)  ·  Clopidogrel (1)  ·  Prasugrel Hydrochloride (1)

Sponsors

Abbott Medical Devices (4)  ·  Brigham and Women's Hospital (1)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  Argentina (2)  ·  Austria (2)  ·  Belgium (2)  ·  Brazil (2)  ·  China (2)  ·  Denmark (2)  ·  France (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Latvia (2)  ·  Netherlands (2)  ·  Norway (2)  ·  Poland (2)

Top investigators

Marie-Claude Morice (2)  ·  Stephan Windecker (2)  ·  C Keith Ozaki, MD (1)  ·  David Saloner, PhD (1)  ·  Gao Runlin, MD, FACC (1)  ·  James Hermiller, MD (1)  ·  Mitch Krucoff, MD (1)  ·  Warren Gasper, MD (1)

Results publications

PMID 25175629, PMID 25940520, PMID 28796809, PMID 41159585

NIH funding

R01HL128816 (1)